127 related articles for article (PubMed ID: 37775348)
1. Oncologic Safety of One-Stage Implant-Based Breast Reconstruction in Breast Cancer Patients With Positive Sentinel Lymph Nodes: A Single-Center Retrospective Study Using Propensity Score Matching.
Zhao J; Xiao C
Clin Breast Cancer; 2024 Jan; 24(1):e1-e8. PubMed ID: 37775348
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer outcomes following immediate breast reconstruction with implants versus autologous flaps: a propensity score-matched study.
Wu ZY; Han J; Kim HJ; Lee JW; Chung IY; Kim J; Lee SB; Son BH; Han HH; Eom JS; Jeong JH; Gong G; Kim HH; Ahn SH; Ko B
Breast Cancer Res Treat; 2022 Jan; 191(2):365-373. PubMed ID: 34755242
[TBL] [Abstract][Full Text] [Related]
3. Preservation of the pectoralis major fascia has no impact on the long-term oncologic outcomes of patients with breast cancer treated with conservative mastectomy and immediate breast reconstruction: A propensity score matching analysis.
Chen AX; Li XX; Guo ZY; Ge J; Yu Y; Wang X; Cao XC; Zhang B
J Plast Reconstr Aesthet Surg; 2023 Nov; 86():231-238. PubMed ID: 37782996
[TBL] [Abstract][Full Text] [Related]
4. A propensity score-matched comparison of recurrence outcomes after immediate implant vs autologous flap reconstruction in patients receiving neoadjuvant chemotherapy for breast cancer.
Wu ZY; Han HH; Kim HJ; Lee JW; Chung IY; Kim J; Lee SB; Son BH; Eom JS; Jung JH; Kim SB; Gong G; Kim HH; Ahn S-; Ko B
Breast Cancer Res Treat; 2021 Jun; 187(2):417-425. PubMed ID: 33740204
[TBL] [Abstract][Full Text] [Related]
5. Axilla lymph node dissection can be safely omitted in patients with 1-2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis.
Gao W; Lu S; Zeng Y; Chen X; Shen K
Breast Cancer Res Treat; 2022 Nov; 196(1):129-141. PubMed ID: 36076127
[TBL] [Abstract][Full Text] [Related]
6. Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence.
Lee KT; Kim S; Jeon BJ; Pyon JK; Mun GH; Ryu JM; Lee SK; Yu J; Kim SW; Lee JE; Nam SJ; Bang SI
JAMA Surg; 2020 Dec; 155(12):1132-1140. PubMed ID: 33026424
[TBL] [Abstract][Full Text] [Related]
7. Long-term Oncologic Outcomes of Immediate Breast Reconstruction vs Conventional Mastectomy Alone for Breast Cancer in the Setting of Neoadjuvant Chemotherapy.
Wu ZY; Kim HJ; Lee JW; Chung IY; Kim JS; Lee SB; Son BH; Eom JS; Kim SB; Jung KH; Gong G; Kim HH; Ahn SH; Ko B
JAMA Surg; 2020 Dec; 155(12):1142-1150. PubMed ID: 33052412
[TBL] [Abstract][Full Text] [Related]
8. Can Axillary Lymph Node Dissection be Omitted in Breast Cancer Patients with Metastatic Sentinel Lymph Nodes Undergoing Mastectomy? A Systematic Review and Meta-Analysis of Real-World Evidence.
Chen F; Li X; Lin X; Chen L; Lin Z; Wu H; Chen J
World J Surg; 2023 Oct; 47(10):2446-2456. PubMed ID: 37249632
[TBL] [Abstract][Full Text] [Related]
9. A Propensity Score-matched Analysis of Long-term Oncologic Outcomes After Nipple-sparing Versus Conventional Mastectomy for Locally Advanced Breast Cancer.
Wu ZY; Han HH; Kim HJ; Chung IY; Kim J; Lee SB; Son BH; Eom JS; Kim SB; Ahn JH; Gong GY; Kim HH; Ahn SH; Ko B
Ann Surg; 2022 Aug; 276(2):386-390. PubMed ID: 33201107
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome and patient satisfaction with the use of bovine-derived acellular dermal matrix (SurgiMend™) in implant based immediate reconstruction following skin sparing mastectomy: A prospective observational study in a single centre.
Headon H; Kasem A; Manson A; Choy C; Carmichael AR; Mokbel K
Surg Oncol; 2016 Jun; 25(2):104-10. PubMed ID: 27312036
[TBL] [Abstract][Full Text] [Related]
11. Nipple-sparing mastectomy: A review of outcomes at a single institution.
Woodward S; Willis A; Lazar M; Berger AC; Tsangaris T
Breast J; 2020 Nov; 26(11):2183-2187. PubMed ID: 33137841
[TBL] [Abstract][Full Text] [Related]
12. Axillary Lymph Node Dissection Does Not Improve Post-mastectomy Overall or Disease-Free Survival among Breast Cancer Patients with 1-3 Positive Nodes.
Joo JH; Kim SS; Son BH; Ahn SD; Jung JH; Choi EK; Ahn SH; Lee JW; Kim HJ; Ko BS
Cancer Res Treat; 2019 Jul; 51(3):1011-1021. PubMed ID: 30322228
[TBL] [Abstract][Full Text] [Related]
13. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
14. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
[No Abstract] [Full Text] [Related]
15. Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.
Tinterri C; Canavese G; Gatzemeier W; Barbieri E; Bottini A; Sagona A; Caraceni G; Testori A; Di Maria Grimaldi S; Dani C; Boni L; Bruzzi P; Fernandes B; Scorsetti M; Zambelli A; Gentile D;
Br J Surg; 2023 Aug; 110(9):1143-1152. PubMed ID: 37471574
[TBL] [Abstract][Full Text] [Related]
16. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.
Shigematsu H; Nishina M; Yasui D; Hirata T; Ozaki S
World J Surg Oncol; 2019 Feb; 17(1):41. PubMed ID: 30797231
[TBL] [Abstract][Full Text] [Related]
17. Retrospective Cohort Study on the Long-term Oncologic Outcomes of Sentinel Lymph Node Mapping Methods (Dye-Only versus Dye and Radioisotope Mapping) in Early Breast Cancer: A Propensity Score-Matched Analysis.
Lim C; Kang E; Jung JG; Cheun JH; Kim HK; Lee HB; Moon HG; Han W
Cancer Res Treat; 2023 Apr; 55(2):562-569. PubMed ID: 36164944
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy.
Chun JW; Kim J; Chung IY; Ko BS; Kim HJ; Lee JW; Son BH; Ahn SH; Lee SB
Sci Rep; 2021 Apr; 11(1):9056. PubMed ID: 33907236
[TBL] [Abstract][Full Text] [Related]
19. Application of the ACOSOG Z0011 criteria to Chinese patients with breast cancer: a prospective study.
Peng Y; Liu M; Li X; Tong F; Cao Y; Liu P; Zhou B; Liu H; Cheng L; Guo J; Xie F; Yang H; Wang S; Wang C; Chen Y; Wang S
World J Surg Oncol; 2021 Apr; 19(1):128. PubMed ID: 33879180
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of non-sentinel lymph node metastasis in breast cancer with 1-2 sentinel lymph node macrometastases underwent total mastectomy: a case-control study.
Huang Z; Wu Z; Zou QQ; Xie YJ; Li LH; Huang YP; Wu FM; Huang D; Pan YH; Yang JR
World J Surg Oncol; 2023 Apr; 21(1):125. PubMed ID: 37024930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
